We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B Turnover 22.5%
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+13.79%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.82B
AUM Growth
+$522M
Cap. Flow
+$73.4M
Cap. Flow %
1.52%
Top 10 Hldgs %
20.44%
Holding
604
New
109
Increased
179
Reduced
173
Closed
43
Avg Time Held
0.2 years
Top 10 Avg Time Held
0.1 years
Top 20 Avg Time Held
0.2 years

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$48.8M
2
CMCSA icon
Comcast
CMCSA
+$46.9M
3
AVY icon
Avery Dennison
AVY
+$38.5M
4
MIDD icon
Middleby
MIDD
+$33M
5
LKQ icon
LKQ Corp
LKQ
+$32.3M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$63.1M
2
TROW icon
T. Rowe Price
TROW
+$47.7M
3
ISRG icon
Intuitive Surgical
ISRG
+$39M
4
PAA icon
Plains All American Pipeline
PAA
+$39M
5
SHW icon
Sherwin-Williams
SHW
+$38.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.65%
2 Financials 14.81%
3 Industrials 14.31%
4 Technology 11.57%
5 Energy 10.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
RMD icon
301
ResMed
RMD
$33.6B
$486K 0.01%
9,205
-600
-6% -$29.1K
2013 Q2
1 quarter
AXIA.PR
302
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
$476K 0.01%
+128,727
New +$423K
2013 Q3
0 quarters
USB.PRN.CL icon
303
DELISTED
U.S. Bancorp
USB.PRN.CL
$475K 0.01%
17,615
– –
2013 Q2
1 quarter
MDT icon
304
Medtronic
MDT
$121B
$474K 0.01%
8,895
-373
-4% -$20.1K
2013 Q2
1 quarter
CF icon
305
CF Industries
CF
$18.3B
$470K 0.01%
11,140
-25
-0.2% -$958
2013 Q2
1 quarter
NOV icon
306
NOV
NOV
$6.74B
$460K 0.01%
6,524
– –
2013 Q2
1 quarter
GWW icon
307
W.W. Grainger
GWW
$62.2B
$458K 0.01%
1,750
– –
2013 Q2
1 quarter
SYK icon
308
Stryker
SYK
$113B
$458K 0.01%
6,770
-540
-7% -$37.3K
2013 Q2
1 quarter
GMCR
309
DELISTED
KEURIG GREEN MTN INC
GMCR
$458K 0.01%
6,077
-1,095
-15% -$86.4K
2013 Q2
1 quarter
LNT icon
310
Alliant Energy
LNT
$17.7B
$456K 0.01%
18,404
+156
+0.9% +$3.99K
2013 Q2
1 quarter
SGNT
311
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$454K 0.01%
22,261
+10,780
+94% +$240K
2013 Q2
1 quarter
VIG icon
312
Vanguard Dividend Appreciation ETF
VIG
$113B
$451K 0.01%
6,474
+1,119
+21% +$77.4K
2013 Q2
1 quarter
FMBI
313
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$448K 0.01%
29,696
-1,736
-6% -$26.4K
2013 Q2
1 quarter
VXX icon
314
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$444K 0.01%
+472
New +$473K
2013 Q3
0 quarters
FULLL
315
DELISTED
Great Elm Capital Corp. 8.25% Notes due 2020
FULLL
$442K 0.01%
17,500
+5,500
+46% +$138K
2013 Q2
1 quarter
VOYA icon
316
Voya Financial
VOYA
$8.47B
$438K 0.01%
15,000
-5,400
-26% -$161K
2013 Q2
1 quarter
EXAM
317
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
$429K 0.01%
+16,500
New +$386K
2013 Q3
0 quarters
TDG icon
318
TransDigm Group
TDG
$62.9B
$425K 0.01%
3,063
-208,306
-99% -$29.7M
2013 Q2
1 quarter
VPL icon
319
Vanguard FTSE Pacific ETF
VPL
$8.47B
$410K 0.01%
6,754
-1,365
-17% -$79.8K
2013 Q2
1 quarter
CMI icon
320
Cummins
CMI
$73.3B
$409K 0.01%
3,076
-200
-6% -$24.7K
2013 Q2
1 quarter
GGP
321
DELISTED
GGP Inc.
GGP
$407K 0.01%
21,086
– –
2013 Q2
1 quarter
NEOG icon
322
Neogen
NEOG
$2.56B
$406K 0.01%
26,740
+3,180
+13% +$45.5K
2013 Q2
1 quarter
AGN
323
DELISTED
Allergan Inc
AGN
$406K 0.01%
4,484
+5
+0.1% +$449
2013 Q2
1 quarter
WHR icon
324
Whirlpool
WHR
$1.84B
$400K 0.01%
2,731
– –
2013 Q2
1 quarter
TRMB icon
325
Trimble
TRMB
$13.9B
$399K 0.01%
13,415
-82,635
-86% -$2.26M
2013 Q2
1 quarter
11 12
13
14 15

Similar funds

CAM
Capstone Asset Management Houston, Texas $3.6B AUM 20.22% 1-Year Est. Return
Virtu KCG Holdings
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
Ronald Blue & Co
Ronald Blue & Co Roswell, Georgia $3.1B AUM 12.82% 1-Year Est. Return
TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
HCM
Holland Capital Management Chicago, Illinois $2.28B AUM 23.08% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return

Geneva Advisors's Q3 2013 Portfolio in Review

As of Q3 2013, Geneva Advisors held 604 positions worth $4.82B, up 12% from $4.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneva Advisors's Q3 2013 filing shows 109 new, 179 increased, 173 reduced and 43 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 185,591 shares worth $58.1M. The largest sale was Monsanto Co, an estimated $63.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Geneva Advisors's largest Q3 2013 buy was Regeneron Pharmaceuticals: 185,591 shares worth $58.1M.
  • Geneva Advisors added most to Comcast in Q3 2013, an estimated $46.9M increase.
  • Geneva Advisors's biggest Q3 2013 reduction was Monsanto Co, cutting an estimated $63.1M.
  • Geneva Advisors fully exited Valmont Industries in Q3 2013, selling an estimated $36.7M.
  • Geneva Advisors's ten largest holdings make up 20% of its $4.82B portfolio in Q3 2013.
  • Geneva Advisors opened 109 new positions and closed 43 in Q3 2013.
  • Geneva Advisors's portfolio value rose 12% quarter-over-quarter to $4.82B.

Based on Geneva Advisors's 13F filing for Q3 2013, filed 4 Nov 2013.